THINK IVIG. WRITE PRIVIGEN Trademark

Trademark Overview

On Thursday, April 4, 2019, a trademark application was filed for THINK IVIG. WRITE PRIVIGEN with the United States Patent and Trademark Office. The USPTO has given the THINK IVIG. WRITE PRIVIGEN trademark a serial number of 88370873. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 4, 2024. This trademark is owned by CSL Behring AG. The THINK IVIG. WRITE PRIVIGEN trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals

Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
think ivig. write privigen

General Information

Serial Number88370873
Word MarkTHINK IVIG. WRITE PRIVIGEN
Filing DateThursday, April 4, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, April 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements

Pseudo MarkTHINK INTRAVENOUS IMMUNOGLOBULIN. WRITE PRIVIGEN
Goods and ServicesHealthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals
Goods and ServicesHealthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
Disclaimer with Predetermined Text"IVIG"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 9, 2019
Primary Code035
First Use Anywhere DateTuesday, November 30, 2021
First Use In Commerce DateTuesday, November 30, 2021
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, April 21, 2019
Primary Code044
First Use Anywhere DateTuesday, November 30, 2021
First Use In Commerce DateTuesday, November 30, 2021

Trademark Owner History

Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH
Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressBern 3014
CH

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, April 4, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 7, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 7, 2023FINAL REFUSAL E-MAILED
Thursday, December 7, 2023SU - FINAL REFUSAL - WRITTEN
Wednesday, October 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 14, 2023NON-FINAL ACTION E-MAILED
Monday, August 14, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, July 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 17, 2023NON-FINAL ACTION E-MAILED
Monday, April 17, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, March 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, March 3, 2023USE AMENDMENT FILED
Friday, March 3, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU EXTENSION 5 GRANTED
Wednesday, August 10, 2022SOU EXTENSION 5 FILED
Friday, August 19, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 10, 2022SOU TEAS EXTENSION RECEIVED
Saturday, February 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 10, 2022SOU EXTENSION 4 GRANTED
Thursday, February 10, 2022SOU EXTENSION 4 FILED
Thursday, February 10, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 10, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 10, 2021SOU EXTENSION 3 FILED
Tuesday, August 10, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 2 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 2 FILED
Wednesday, February 10, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020SOU EXTENSION 1 GRANTED
Wednesday, August 12, 2020SOU EXTENSION 1 FILED
Wednesday, August 12, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 20, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, June 20, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, June 20, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, June 12, 2019ASSIGNED TO EXAMINER
Sunday, April 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2019NEW APPLICATION ENTERED

Related Keywords

privigen write ivig think healthcare patients professionals caregivers impact their patient families information treatment